ProFESS trial: any lessons to learn for future anti-platelet trials?

Int J Stroke. 2009 Dec;4(6):458-60. doi: 10.1111/j.1747-4949.2009.00382.x.
No abstract available

MeSH terms

  • Aged
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Brain / pathology
  • Cerebral Arteries / pathology
  • Clopidogrel
  • Dipyridamole / adverse effects
  • Dipyridamole / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Risk Factors
  • Risk Reduction Behavior
  • Stroke / classification
  • Stroke / drug therapy*
  • Stroke / pathology
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Dipyridamole
  • Clopidogrel
  • Ticlopidine
  • Aspirin